Program
Capecitabine
Also written as “capecitabine”, “capecitabine [Xeloda]” and “Utidelone in combination with capecitabine”.
Its studies are mostly in Breast Neoplasms · Colorectal Neoplasms · Stomach Neoplasms · Pancreatic Neoplasms · Neoplasms, led by 13 companies.
Drug pageCapecitabine: every studyMany companies study it; this page follows only the 72 they lead. All 947 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Hoffmann-La Roche | 430 open or running | phase 4since Jul 12, 2004 | May 2, 2000 | none ahead |
| Sanofiits history only | 90 open or running | phase 3since Apr 20, 2004 | Apr 20, 2004 | none ahead |
| R-Pharmits history only | 60 open or running | phase 3since Mar 26, 2004 | Nov 12, 2002 | none ahead |
| Novartisits history only | 41 open or running | phase 3since Jul 26, 2007 | Jul 26, 2007 | Apr 14, 2027phase 2 · NCT06247995 |
| Qilu Pharmaceuticalits history only | 21 open or running | phase 2since Jun 1, 2024 | Feb 10, 2018 | none ahead |
| Academy Military Medical Science, Chinaits history only | 10 open or running | phase 2since Jul 14, 2008 | Jul 14, 2008 | none ahead |
| Bio-Cancer Treatment Internationalits history only | 10 open or running | phase 2since Mar 14, 2014 | Mar 14, 2014 | none ahead |
| EBG MedAustronits history only | 11 open or running | no phasesince May 10, 2021 | May 10, 2021 | Dec 31, 2026NCT04894643 |
| iOMEDICOits history only | 10 open or running | phase 4since Aug 28, 2014 | Aug 28, 2014 | none ahead |
| NovoCureits history only | 10 open or running | no phasesince Feb 20, 2020 | Feb 20, 2020 | none ahead |
| Pharmatech Oncologyits history only | 10 open or running | phase 2since Nov 9, 2001 | Nov 9, 2001 | none ahead |
| Pierre Fabreits history only | 10 open or running | phase 2since Oct 3, 2016 | Oct 3, 2016 | none ahead |
| Prologue Research Internationalits history only | 10 open or running | phase 3since Jun 5, 2003 | Jun 5, 2003 | none ahead |
Also a collaborator on its studies: Exelixis, Clovis Oncology, Johnson & Johnson, Parexel, Baili-Bio (Chengdu) Pharmaceutical, Zai Lab, Chengdu Biostar Pharmaceuticals, Regeneron Pharmaceuticals, GlaxoSmithKline and Yakult Honsha.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Hoffmann-La Roche only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 27 studies since May 2, 2000.
- Jun 1, 2010Phase 2 study in Colorectal NeoplasmsNCT01135498 · 90 enrolled · Spain
- Oct 22, 2010Phase 2 study in Colorectal NeoplasmsNCT01227707 · 43 enrolled · Italy
- Feb 3, 2011Phase 2 study in Breast NeoplasmsNCT01290718 · 4 enrolled · Taiwan
- Oct 10, 2011Phase 3 study in Stomach NeoplasmsNCT01450696 · 296 enrolled · United States, Australia, Bosnia and Herzegovina and more
- Dec 10, 2012Phase 2 study in Stomach NeoplasmsNCT01748773 · 34 enrolled · Turkey
- Dec 3, 2013Phase 2 study in Liver NeoplasmsNCT02013830 · 45 enrolled · Australia, Hong Kong, Singapore and more
- Nov 11, 2014Phase 2 study in Colorectal NeoplasmsNCT02291289 · 1,044 enrolled · Argentina, Belgium, Bosnia and Herzegovina and more
- Sep 24, 20152 phase 3 studies in Stomach NeoplasmsNCT02560974, NCT02563054
- Sep 30, 2015Phase 2 study in Pancreatic NeoplasmsNCT02565641 · 63 enrolled · Korea, Republic of
- Oct 1, 20152 phase 4 studies in Colorectal NeoplasmsNCT02567331, NCT02581423
- Oct 14, 2015Phase 2 study in Carcinoma, HepatocellularNCT02576964 · 16 enrolled · China, Taiwan, Thailand
- Nov 16, 2015Phase 2 study in Nasopharyngeal NeoplasmsNCT02608073 · 45 enrolled · Hong Kong, Indonesia, Malaysia and more
- Feb 25, 2016Phase 2 study in Rectal NeoplasmsNCT02694718 · 60 enrolled · Switzerland
- Jul 25, 2016Phase 2 study in Breast NeoplasmsNCT02846428 · 182 enrolled · France
TargetBeta
“Thymidylate synthase inhibitor; RNA inhibitor”ChEMBL 37, by rule
Other programs on TYMS
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Pemetrexedrule | Eli Lilly | phase 4 | 141 |
| Fluorouracilrule | Sanofi | phase 4 | 82 |
| Tegafurrule | Otsuka | phase 3 | 25 |
Studies
All 43 Hoffmann-La Roche leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02846428Breast Neoplasms · France | 2 | Completed | Dec 2011 | 182 |
| NCT02694718Rectal Neoplasms · Switzerland | 2 | Completed | Aug 2006 | 60 |
| NCT02608073Nasopharyngeal Neoplasms · Hong Kong, Indonesia, Malaysia and more | 2 | Completed | Nov 2009 | 45 |
| NCT02581423Colorectal Neoplasms · Bulgaria | 4 | Completed | Mar 2007 | 63 |
| NCT02576964Carcinoma, Hepatocellular · China, Taiwan, Thailand | 2 | Completed | Nov 2008 | 16 |
| NCT02567331Colorectal Neoplasms · Bulgaria | 4 | Completed | Apr 2006 | 28 |
| NCT02565641Pancreatic Neoplasms · Korea, Republic of | 2 | Completed | Sep 2006 | 63 |
| NCT02563054Stomach Neoplasms · Argentina, Belize, Brazil and more | 3 | Completed | Aug 2010 | 316 |
| NCT02560974Stomach Neoplasms · China, Korea, Republic of, Taiwan | 3 | Completed | Nov 2012 | 1,035 |
| NCT02291289Colorectal Neoplasms · Argentina, Belgium, Bosnia and Herzegovina and more | 2 | Completed | May 31, 2019 | 1,044 |
| NCT02013830Liver Neoplasms · Australia, Hong Kong, Singapore and more | 2 | Completed | Mar 2008 | 45 |
| NCT01748773Stomach Neoplasms · Turkey | 2 | Completed | Aug 21, 2015 | 34 |
| NCT01450696Stomach Neoplasms · United States, Australia, Bosnia and Herzegovina and more | 3 | Terminated | Feb 2015 | 296 |
| NCT01290718Breast Neoplasms · Taiwan | 2 | Terminated | Dec 2012 | 4 |
| NCT01227707Colorectal Neoplasms · Italy | 2 | Completed | Aug 2010 | 43 |
| NCT01135498Colorectal Neoplasms · Spain | 2 | Completed | Apr 2010 | 90 |
| NCT01130337Stomach Neoplasms · Spain | 2 | Completed | Jun 2014 | 36 |
| NCT01118377Brainstem Glioma · United States | 2 | Completed | Jan 2013 | 45 |
| NCT01077739Colorectal Neoplasms · Belgium | 2 | Completed | Jan 2012 | 75 |
| NCT01077726Breast Neoplasms · France | 2 | Completed | Dec 2010 | 3 |
| NCT00977379Breast Neoplasms · France | 2 | Terminated | Feb 2011 | 24 |
| NCT00929240Breast Neoplasms · Brazil, China, Egypt and more | 3 | Completed | Jun 2014 | 287 |
| NCT00925769Pancreatic Neoplasms · Austria | 1 | Completed | Dec 2013 | 32 |
| NCT00885755Breast Neoplasms · Australia, Spain, Sweden and more | 2 | Completed | Feb 18, 2013 | 33 |
| NCT00811135Breast Neoplasms · Denmark, France, Russian Federation and more | 2 | Completed | Dec 2015 | 88 |
| NCT00796718Colorectal Neoplasms · Slovakia | 2 | Completed | Aug 2010 | 62 |
| NCT00623805Colorectal Neoplasms · Turkey | 3 | Completed | May 2012 | 123 |
| NCT00577031Colorectal Neoplasms · Italy | 4 | Completed | Aug 2011 | 205 |
| NCT00576901Breast Neoplasms · Spain | 2 | Terminated | Jun 2009 | 23 |
| NCT00532948Glioma · United States | 1 | Completed | Oct 2010 | 24 |
| NCT00502671Colorectal Neoplasms · Russian Federation | 4 | Completed | Mar 2012 | 228 |
| NCT00448136Neoplasms · France | 2 | Completed | Nov 2011 | 83 |
| NCT00345761Colorectal Neoplasms · Japan | 2 | Completed | Oct 2008 | 64 |
| NCT00121836Breast Neoplasms · United States | 4 | Completed | Dec 2008 | 109 |
| NCT00118755Colorectal Neoplasms | 2 | Completed | Apr 2009 | 435 |
| NCT00112918Colorectal Neoplasms · United States | 3 | Completed | Jun 2010 | 3,451 |
| NCT00087620Breast Neoplasms · United States | 4 | Terminated | Oct 2004 | |
| NCT00077857Breast Neoplasms · United States, Bosnia and Herzegovina, China and more | 2 | Completed | Mar 2010 | 470 |
| NCT00069121Colorectal Neoplasms · United States, Australia, Belgium and more | 3 | Completed | Apr 21, 2011 | 1,886 |
| NCT00069095Colorectal Neoplasms · United States, Australia, Austria and more | 3 | Completed | Jan 2006 | 2,035 |
| NCT00022698Colorectal Neoplasms · United States | 2 | Completed | Dec 2004 | 67 |
| NCT00009737Colorectal Neoplasms · United States, Argentina, Australia and more | 3 | Completed | Apr 2004 | 1,987 |
| NCT00005649Breast Neoplasms · United States | 2 | Completed | Jul 4, 2002 |
How it is read
Names in the registry
- “Capecitabine”, 62 entries
- “capecitabine”, 16 entries
- “capecitabine [Xeloda]”, 12 entries
- “Utidelone in combination with capecitabine”, 3 entries
- “Capecitabine [Xeloda]”, 3 entries
Conditions, from the studies’ own filings
- Breast Neoplasms, 44 studies
- Colorectal Neoplasms, 21 studies
- Stomach Neoplasms, 16 studies
- Pancreatic Neoplasms, 6 studies
- Neoplasms, 5 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.